Skip to main content

Pregnancy Prevention

3
Pipeline Programs
5
Companies
6
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
2
Levonorgestrel 0.15 milligramPhase 21 trial
Levonorgestrel 1.5mgPhase 21 trial
Active Trials
NCT06306131Recruiting22Est. Nov 2025
NCT05695352Recruiting21Est. Nov 2025
Innovation Pharmaceuticals
1 program
1
Healthy Adolescent TransitionsPhase 21 trial
Active Trials
NCT03194672Completed331Est. Mar 2024
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Project LegacyN/A1 trial
Active Trials
NCT03366636Completed571Est. Mar 2021
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Teen Outreach Program with Media EnhancementN/A1 trial
Active Trials
NCT01535651Completed852Est. May 2016
Teva
TevaIsrael - Petach Tikva
1 program
DR-103PHASE_31 trial
Active Trials
NCT00996580Completed3,597Est. Sep 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TevaDR-103
Human BioSciencesLevonorgestrel 0.15 milligram
Human BioSciencesLevonorgestrel 1.5mg
Innovation PharmaceuticalsHealthy Adolescent Transitions
Angeles TherapeuticsProject Legacy
Colorado TherapeuticsTeen Outreach Program with Media Enhancement

Clinical Trials (6)

Total enrollment: 5,394 patients across 6 trials

NCT00996580TevaDR-103

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Start: Oct 2009Est. completion: Sep 20113,597 patients
Phase 3Completed
NCT06306131Human BioSciencesLevonorgestrel 0.15 milligram

Phase II Study of Ovulation in Obese Women

Start: Dec 2023Est. completion: Nov 202522 patients
Phase 2Recruiting
NCT05695352Human BioSciencesLevonorgestrel 1.5mg

Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days

Start: Jun 2022Est. completion: Nov 202521 patients
Phase 2Recruiting
NCT03194672Innovation PharmaceuticalsHealthy Adolescent Transitions

Healthy Adolescent Transitions (HAT)

Start: Aug 2017Est. completion: Mar 2024331 patients
Phase 2Completed
NCT03366636Angeles TherapeuticsProject Legacy

Project Legacy Impact Evaluation Study

Start: Oct 2017Est. completion: Mar 2021571 patients
N/ACompleted
NCT01535651Colorado TherapeuticsTeen Outreach Program with Media Enhancement

Using Social Media to Enhance the Impact of the Teen Outreach Program

Start: Sep 2011Est. completion: May 2016852 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 5,394 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.